Guangdong Biolight Meditech Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology

Masimo MASI and Biolight today jointly announced both a worldwide technology licensing agreement and the launch of Masimo rainbow® SET Pulse CO-Oximetry technology in Biolight's new generation of modular patient monitors. The agreement allows Biolight to incorporate the breakthrough noninvasive blood constituent measurement capabilities of Masimo rainbow SET into Biolight's Anyview Series of modular monitors and the Measure-Through Motion and Low Perfusion pulse oximetry capabilities of Masimo SET across Biolight's product line of multiparameter patient monitors - facilitating early detection and treatment of life-threatening conditions.